]i responses, whereas a combination of ANG II and PD-123319 had no effect. These data demonstrate for the first time that direct microinjection of ANG II in single PTCs increases [Ca 2ϩ ]i by stimulating intracellular AT 1 receptors and releases Ca 2ϩ from intracellular stores, suggesting that intracellular ANG II may play a physiological role in PTC function. intracellular calcium; kidney; microinjection; proximal tubules; receptor-mediated endocytosis ANG II IS a powerful peptide hormone that exerts both endocrine and paracrine actions in the kidney (3, 11, 16, 20, 35) . Physiologically, ANG II maintains body sodium and fluid balance and blood pressure homeostasis by stimulating tubular sodium and fluid reabsorption as well as through its direct effects on the vasculature (11, 20, 33, 38) . However, sustained increases in intrarenal ANG II levels because of local formation and/or uptake of circulating and locally formed extracellular ANG II by proximal tubule cells (PTCs) may contribute to sodium retention and promote cell growth and proliferation, leading to hypertension-mediated renal injury (19, 21, 36) . It is now recognized that PTCs express all necessary components of the renin-angiotensin system (RAS), including the precursor angiotensinogen as well as renin and angiotensin-converting enzyme (ACE; see Refs. 12, 14, 16, 28) . Moreover, ANG II concentrations in proximal tubular fluid and renal cortical interstitial fluid are greater than can be explained by the circulating ANG II concentrations (2, 22, 27) . These findings suggest that substantial amounts of ANG II may be generated within PTCs. However, there is also mounting evidence that binding of extracellular ANG II to membrane-bound angiotensin type 1 (AT 1 ) receptors promotes internalization of extracellular ANG II into various cells, including vascular smooth muscle cells (VSMCs; see Refs. 1 and 9) and renal epithelial cells (13, 25, 31) . In vivo, ANG II has been shown to accumulate in the kidney after salt restriction (17) and chronic ANG II administration (33, 36, 40, 41) , where internalized extracellular ANG II was colocalized with AT 1A receptors in the endosomal compartments of the rat renal cortex (36). These studies suggest that, after internalization, ANG II may also exert an important intracrine role in regulating PTC function.
PTCs express angiotensinogen, renin, and angiotensin-converting enzyme mRNAs, suggesting the presence of high levels of intracellular ANG II. We determined if microinjection of ANG II directly in single PTCs increases intracellular calcium concentration ([Ca 2ϩ ]i) and, if so, elucidated the cellular mechanisms involved. Changes in [Ca 2ϩ ]i responses were studied by fluorescence imaging using the Ca 2ϩ indicator fluo 3. ANG II (1 nM) was microinjected directly in the cells, whereas cell-surface angiotensin type 1 (AT1) receptors were blocked by losartan (10 M). When ANG II (1 nM) was added to the perfusate, there was a marked increase in [Ca 2ϩ ]i that was blocked by extracellular losartan. With losartan in the perfusate, intracellular microinjection of ANG II elicited a robust increase in cytoplasmic [Ca 2ϩ ]i that peaked at 30 s (basal: 2.2 Ϯ 0.3 vs. ANG II: 14.9 Ϯ 0.4 relative fluorescence units; P Ͻ 0.01). Chelation of extracellular Ca 2ϩ with EGTA (2 mM) did not alter microinjected ANG IIinduced [Ca 2ϩ ]i responses (Ca 2ϩ free ϩ ANG II: 12.3 Ϯ 2.6 relative fluorescence units, not significant vs. ANG II); however, pretreatment with thapsigargin to deplete intracellular Ca 2ϩ stores or with U-73122 to inhibit phospholipase C (1 M each) markedly attenuated microinjected ANG II-induced [Ca 2ϩ ]i responses. Combined microinjection of ANG II and losartan abolished [Ca 2ϩ ]i responses, whereas a combination of ANG II and PD-123319 had no effect. These data demonstrate for the first time that direct microinjection of ANG II in single PTCs increases [Ca 2ϩ ]i by stimulating intracellular AT 1 receptors and releases Ca 2ϩ from intracellular stores, suggesting that intracellular ANG II may play a physiological role in PTC function. intracellular calcium; kidney; microinjection; proximal tubules; receptor-mediated endocytosis ANG II IS a powerful peptide hormone that exerts both endocrine and paracrine actions in the kidney (3, 11, 16, 20, 35) . Physiologically, ANG II maintains body sodium and fluid balance and blood pressure homeostasis by stimulating tubular sodium and fluid reabsorption as well as through its direct effects on the vasculature (11, 20, 33, 38) . However, sustained increases in intrarenal ANG II levels because of local formation and/or uptake of circulating and locally formed extracellular ANG II by proximal tubule cells (PTCs) may contribute to sodium retention and promote cell growth and proliferation, leading to hypertension-mediated renal injury (19, 21, 36) . It is now recognized that PTCs express all necessary components of the renin-angiotensin system (RAS), including the precursor angiotensinogen as well as renin and angiotensin-converting enzyme (ACE; see Refs. 12, 14, 16, 28) . Moreover, ANG II concentrations in proximal tubular fluid and renal cortical interstitial fluid are greater than can be explained by the circulating ANG II concentrations (2, 22, 27) . These findings suggest that substantial amounts of ANG II may be generated within PTCs. However, there is also mounting evidence that binding of extracellular ANG II to membrane-bound angiotensin type 1 (AT 1 ) receptors promotes internalization of extracellular ANG II into various cells, including vascular smooth muscle cells (VSMCs; see Refs. 1 and 9) and renal epithelial cells (13, 25, 31) . In vivo, ANG II has been shown to accumulate in the kidney after salt restriction (17) and chronic ANG II administration (33, 36, 40, 41) , where internalized extracellular ANG II was colocalized with AT 1A receptors in the endosomal compartments of the rat renal cortex (36) . These studies suggest that, after internalization, ANG II may also exert an important intracrine role in regulating PTC function.
Although it is widely accepted that ANG II exerts diverse effects by activating cell-surface AT 1 receptors in targeted cells (6, 39) , recent studies suggest that intracellular ANG II, either accumulated through internalization or synthesized within the cells, is also capable of inducing intracellular responses (5, 7-10). Haller et al. (10) demonstrated that microinjection of ANG II in VSMCs increased intracellular [Ca 2ϩ ] i , and this response was blocked by intracellular administration of candesartan, an AT 1 receptor antagonist (10) . Similarly, dialysis of ANG II in VSMCs or cardiac myocytes has been shown to stimulate voltage-operated Ca 2ϩ channels (8) or reduce inward calcium currents (7). Cook et al. (5) recently reported that ANG II generated within hepatocytes appeared to exert mitogenic effects. Although PTCs are known to produce and accumulate high levels of ANG II, it remains unclear whether intracellular ANG II exerts any role in regulating proximal tubular cell function. PTCs are structurally and functionally different from VSMCs, hepatocytes, or cardiac myocytes, and they may have completely different responses to extracellular and intracellular ANG II. Studies by Schelling and Linas (25) suggested that endocytosis of the ANG II-AT 1 receptor complex may be required for full expression of biological actions of ANG II in PTCs. Moreover, Thekkumkara et al. (31, 32) 
MATERIALS AND METHODS
PTC culture. Cultured PTCs were obtained from American Type Culture Collection and subcultured as described previously (16, 24, 28) . These cells were initially derived from the S 1 segment of rabbit kidney proximal tubules and have been shown to express electrolyte transporters and major components of the RAS, including angiotensinogen, renin, ACE, and ANG II receptors (24) . In the present study, unless specified otherwise, PTCs were subcultured on glass coverslips for measurements of [Ca 2ϩ ]i responses in complete DMEM-F-12 growth medium supplemented with 50 nM hydrocortisone, 5% heat-inactivated FBS, 100 U/ml penicillin, and 100 g/ml streptomycin. Cells were maintained at 37°C and 95% O 2-5% CO2 and fed every 2-3 days. Serum was removed from the medium for 24 h before the experiments began (16, 28) .
Expression of AT 1 receptor protein in PTCs. To confirm that PTCs we used express AT1 receptors, the cells were split into six-well plates and grown to 80% confluence as described above. After being serum starved for 24 h, cells were washed two times with ice-cold PBS and lysed with a modified RIPA buffer [50 mM Tris ⅐ HCl, 1% Nonidet P-40, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride (PMSF), 1 g/ml each of aprotinin, leupeptin, and pepstatin, 1 mM Na 3VO4, and 1 mM NaF, pH 7.4]. Samples were extracted as described previously (12) , and protein concentrations were determined using a bicinchoninic acid protein assay kit (Pierce). Proximal tubule protein samples (10 g each) were electrophoretically separated on 8 -16% Tris-glycine gels at 120 volts for 1.5-2 h. After SDS separation, proteins were transferred to Millipore Immobilon-P membranes using a Bio-Rad Trans-Blot SemiDry system powered by a Bio-Rad Power-Pac HC (25 volts, 0.12 ampere, 1.5 h). The membranes were blotted overnight at 4°C with 5% nonfat dry milk and incubated for 3 h at room temperature with a primary rabbit anti-AT 1 receptor polyclonal antibody raised against the NH2-terminal extracellular domain of AT1 receptors (1:200, SC-1173; Santa Cruz; see Ref. 12) . To determine the specificity of the antibody, an AT 1 receptor-selective blocking peptide was used to treat the samples before running the Western blots (SC-1173BP; Santa Cruz). To ensure equal protein loading, the same membranes were treated with a stripping buffer (Pierce) for 20 min, blotted with 5% nonfat dry milk, and reprobed with a mouse anti-␤-actin monoclonal antibody at 1:2,000 (Sigma-Aldrich). Western blot signals were detected using enhanced chemiluminescence (Amersham) and analyzed using a microcomputer imaging device with a digital camera (MCID; Imaging Research).
Measurement of intracellular ANG II in PTCs.
To confirm that PTCs we used produce endogenous ANG II and exposure of these cells to extracellular ANG II increases intracellular ANG II levels via AT 1 receptor-mediated endocytosis, cells were treated with vehicle (serum-free medium), ANG II (1 nM), or ANG II plus losartan (10 M) to block receptor-mediated endocytosis for 60 min at 37°C. After treatment, the medium was removed, and the cells were washed two times with ice-cold PBS and then washed one time with ice-cold acid buffer (5 mM acetic acid, 150 mM NaCl, pH 2.5) to remove any remaining cell membrane-bound ANG II as described previously (1, 9, 13, 32) . ANG II was extracted from PTCs in a buffer containing 20 mM Tris ⅐ HCl, 10 mM EDTA, 5 mM EGTA, 5 mM mercaptoethanol, 50 g/ml PMSF, 1 g/ml aprotinin, and 1 g/ml pepstatin and measured using a sensitive and specific ANG II enzyme immunoassay kit (Biochem/Peninsula). Protein concentration in each sample was used to calculate final ANG II levels expressed as picograms per milligram protein.
Monitoring [Ca 2ϩ ]i responses in single PTCs. Subconfluent PTCs were sparsely plated on glass coverslips and loaded with the calciumsensitive fluorescent dye fluo 3-AM (2 M; Molecular Probes), which was prepared in PBS for 30 min at 37°C (10, 18) . After incubation, coverslips with attached cells were rinsed two times with PBS to remove extracellular dye and extracellular agonist(s) and placed inside a perfusion chamber mounted on a Nikon Diaphot 200 inverted microscope with a TE-FM epifluorescence attachment and a fluorescence filter suitable for fluo 3 (excitation: 488-nm wavelength; emission: 526; see Ref. 10 ). The cells were continuously maintained in the perfusate (10 mM HEPES, 1.5 mM CaCl 2, 145 mM NaCl, 5 mM KCl, 0.5 Na 2HPO4, 6 mM glucose, and 0.5 mM MgSO4, pH 7.4) at 37°C. The [Ca 2ϩ ]i responses to extracellular and intracellular ANG II were recorded with a digital camera and microcomputer imaging device (Imaging Research), first at basal levels and then at 5-s intervals after microinjection of ANG II until responses returned to baseline.
Effect of extracellular ANG II and activation of cell-surface AT 1 receptors on [Ca 2ϩ ]i in PTCs.
Experiments were first carried out to confirm that extracellular ANG II increases [Ca 2ϩ ]i in PTCs and that these effects are blocked when losartan is added to the perfusate. ANG II was added to the perfusate at 1 nM and losartan at 10 M. These concentrations were based on the observations that proximal tubule fluid and interstitial fluid contain nanomolar levels of ANG II (2, 22, 27) and that at 10 M losartan completely displaced ANG II receptor binding in rat proximal tubules (36 -38) .
Effect of intracellular microinjection of ANG II on [Ca 2ϩ ]i in single PTCs. To determine whether intracellular ANG II increases [Ca 2ϩ ]i, ANG II (1 nM; Bachem) was microinjected directly into single PTCs while blocking cell-surface AT 1 receptors with losartan in the perfusate (10 M; Fig. 1 ). Intracellular microinjection of ANG II was carried out using a Narishige micromanipulator and microinjector at a volume of ϳ70 -100 fl/cell with a glass micropipette (10) . Success of intracellular microinjection of ANG II was confirmed using FITC-labeled ANG II (Molecular Probes) to follow intracellular trafficking of microinjected FITC-ANG II and to exclude possible leaking of microinjected ANG II in the extracellular space (Fig. 1) .
Role of intracellular AT 1 [Ca 2ϩ ]i responses between different groups of cells were analyzed using one-way ANOVA followed by Dunnett's comparison between group means, taking P Ͻ 0.05 as significant.
RESULTS

Western blot of AT 1 receptor protein in PTCs.
Western blot showed a single protein band of ϳ42 kDa ( Fig. 2A, top) in PTCs, which was markedly inhibited by an AT 1 receptorselective blocking peptide (Fig. 2, A and B) . The AT 1 receptor protein detected is consistent with the AT 1 receptor reportedly expressed in the rat kidney (12) . When the same membranes were stripped and reprobed with an anti-␤-actin antibody, equal protein loading was confirmed ( Fig. 2A, bottom) . Thus these results confirm that PTCs used in the present study express specific AT 1 receptor protein.
Intracellular ANG II levels in PTCs. However, the fluorescence calcium imaging we used could not quantify the differences between nuclear and cytosolic responses. The [Ca 2ϩ ] i response returned to baseline levels ϳ3 min after microinjection (2.6 Ϯ 0.3 relative fluorescence units). Similar calcium responses were observed after microinjection of FITC-ANG II (n ϭ 5), which was trafficked through the cytoplasm (Fig. 1D) . In a separate group of cells (n ϭ 6), intracellular microinjection of a similar volume of the buffer used for ANG II microinjection did not induce a significant [ (7, 8) . In the present study, we examined if increases in [Ca 2ϩ ] i induced by microinjected ANG II are altered by removing extracellular Ca 2ϩ from the perfusate (Ca 2ϩ -free medium ϩ 2 mM EGTA). In these experiments, ANG II was microinjected at the same rate and concentration except that extracellular Ca 2ϩ was completely removed. Figure  7 , A-F, shows the time-dependent changes in [Ca 2ϩ ] i responses in a representative PTC, and Fig. 7G shows quantitated data from a group of cells (n ϭ 8 ] i responses to microinjected ANG II, PTCs were first treated with 1 M thapsigargin for 30 min to deplete intracellular calcium stores before microinjecting ANG II. Thapsigargin has been widely used to study the role of intracellular calcium mobilization in agonist-induced [Ca2ϩ] i signaling in cardiovascular and renal cells (10, 15, 18) . Figure 8A shows that pretreatment of PTCs with thapsigargin completely abolished the increases in [Ca 2ϩ ] i induced by microinjected ANG II (3.6 Ϯ 1.2 relative fluorescence units, NS vs. basal; n ϭ 6). 
Role of activation of PLC on [
DISCUSSION
The present study demonstrates for the first time that microinjection of ANG II directly in single PTCs increases [Ca 2ϩ ] i levels by activating intracellular AT 1 receptors. Because [Ca 2ϩ ] i responses to microinjected ANG II were elicited while extracellular losartan was applied to block cell-surface AT 1 receptors, the results indicate that the microinjected ANG II exerted an intracellular effect. Furthermore, because [Ca 2ϩ ] i responses to microinjected ANG II were abolished by coadministration of losartan but not PD-123319, and because removal of extracellular Ca 2ϩ did not affect the intracellular actions of microinjected ANG II, our results suggest that intracellular AT 1 receptors, either internalized from cell membranes or synthesized within the cell, mediate the observed effects via an intracellular mechanism(s). Our results are consistent with previous observations that microinjection of ANG II in VSMCs increased [Ca 2ϩ ] i (10) and suggest that intracellular ANG II plays an important intracrine role in PTC function.
Re and associates (5, 23) have supported the concept that intracellular ANG II may play an important intracrine role in hepatocytes and cardiovascular cells. Although intracellular ANG II has been shown to have significant effects in nonrenal cells, it remains unclear if it exerts any biological or physiological role in PTCs. Several lines of evidence suggest that intracellular ANG II may play a role in PTC function. Expression of all necessary components of the RAS in these cells strongly suggests such a possibility (2, 14, 16, 28, 36) . Moreover, high levels of ANG II in proximal tubular fluid and interstitial fluid compartments may promote AT 1 receptormediated endocytosis of ANG II in PTCs, where it could induce intracellular responses (2, 22, 36) . Imig et al. (14) demonstrated the presence of ANG I, ANG II, ACE, and AT 1A receptors in rat renal cortical endosomes; most were likely of the PTC origin. Further studies by us demonstrated increased accumulation of extracellular ANG II in endosomes and intermicrovillar clefts isolated from the renal cortex of rats chronically infused with ANG II (36) . However, it has not been shown whether intracellular ANG II, either synthesized intracellularly or internalized from extracellular compartments, exerts a physiological effect. Schelling and Linas (25) demonstrated that, in isolated PTCs, phenylarsine oxide, which inhibits ANG II receptor internalization, also blocks ANG IIstimulated proximal tubule sodium transport. This suggests indirectly that ANG II-dependent proximal tubule sodium transport requires receptor-mediated endocytosis of ANG II. In the present study, we directly microinjected ANG II in single PTCs and monitored changes in [Ca 2ϩ ] i signaling. To ensure that [Ca 2ϩ ] i responses to microinjected ANG II were not mediated by cell-surface AT 1 receptors, we added losartan to the perfusate to block membrane AT 1 receptors while injecting ANG II in the cells, as described by Haller et al. (10) ] i levels in response to intracellular ANG II. Thus the effects of extracellular Ca 2ϩ on the [Ca 2ϩ ] i responses to microinjected ANG II appear to be dependent on the cells studied. For example, depletion of intracellular Ca 2ϩ stores with cyclopiazonic acid or thapsigargin markedly attenuated ANG II-induced constriction of pre-and postglomerular arterioles in the kidney (15, 18) .
The present study shows that, in PTCs, the [Ca 2ϩ ] i responses to microinjected ANG II are mediated primarily by activating AT 1 receptors inside PTCs. This conclusion is supported by previous observations that AT 1 receptors predominate in proximal tubules (36, 37) (8) . However, they contrast with the effect of losartan in cardiac myocytes, where losartan did not block intracellular ANG II-induced changes in membrane calcium currents (7) . The reason for the differences between cardiac myocytes and PTCs is not clear. It is well documented that AT 1 receptors are internalized in the endosomal compartments after exposure to extracellular ANG II in VSMCs (1, 9) and renal epithelial cells (13, 32, 33) . Moreover, AT 1A receptors have been shown to colocalize with ANG II in isolated rat renal cortical endosomes derived primarily from PTCs (14, 36 (6, 9, 26) . Increases in IP 3 and diacylglycerol in turn induce intracellular [Ca 2ϩ ] i mobilization and activation of protein kinase C (9, 26, 34) . Together with inhibition of adenylyl cyclase to decrease cAMP production, these intracellular signaling pathways play an important role in ANG IIregulated proximal sodium and fluid transport. In the present study, we found that intracellular ANG II-induced increases in [Ca 2ϩ ] i could be prevented by pretreating the cells with the PLC inhibitor U-73122. Interestingly, Schelling et al. (26) reported that inhibition of PLC with U-73122 decreased apical ANG II-induced sodium flux in isolated rat PTCs. It is therefore likely that activation of PLC is required for both extracellular and intracellular ANG II-induced calcium signaling and sodium transport in PTCs.
In summary, we have demonstrated for the first time that intracellular microinjection of ANG II in single PTCs increases [Ca 2ϩ ] i and that these responses do not depend significantly on influx of extracellular Ca 2ϩ but instead require activation of intracellular AT 1 receptors and PLC. Our results suggest that intracellular ANG II, either derived from endocytosis of extracellular ANG II or synthesized within the cell, exerts an important intracrine role in [Ca 2ϩ ] i signaling in PTCs. However, it remains unclear how the increase in [Ca 2ϩ ] i in response to intracellular ANG II stimulation is related to the known effects of ANG II on proximal tubular sodium and fluid transport. Early studies by Taylor and Windhager (30) showed that marked elevation of [Ca 2ϩ ] i was associated with reduced transepithelial sodium transport. By contrast, small increases in [Ca 2ϩ ] i have been reported to stimulate sodium flux in cultured renal epithelial cells (30) . Moreover, the complex intracellular mechanisms by which microinjected ANG II increases [Ca 2ϩ ] i and regulates sodium transport in PTCs remain to be investigated. Extracellular ANG II has been shown to increase [Ca 2ϩ ] i by promoting extracellular Ca 2ϩ influx or by [Ca 2ϩ ] i release from intracellular stores in renal epithelial cells (4, 34) ; intracellular ANG II may mobilize [Ca 2ϩ ] i primarily via an intracellular mechanism(s). 
